<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2021, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 09 Jul 2021 16:05:00 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Vinings Holdings, Inc. to be Renamed Coeptis Therapeutics, Inc.</title>
   <link>http://www.streetinsider.com/Press+Releases/Vinings+Holdings%2C+Inc.+to+be+Renamed+Coeptis+Therapeutics%2C+Inc./18662173.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Vinings+Holdings%2C+Inc.+to+be+Renamed+Coeptis+Therapeutics%2C+Inc./18662173.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vinings+Holdings%2C+Inc.+to+be+Renamed+Coeptis+Therapeutics%2C+Inc./18662173.html</guid>
   <pubDate>Fri, 09 Jul 2021 16:05:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Vinings Holdings, Inc. to be Renamed Coeptis Therapeutics, Inc.</title>
   <link>http://www.streetinsider.com/Press+Releases/Vinings+Holdings%2C+Inc.+to+be+Renamed+Coeptis+Therapeutics%2C+Inc./18662173.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Vinings+Holdings%2C+Inc.+to+be+Renamed+Coeptis+Therapeutics%2C+Inc./18662173.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vinings+Holdings%2C+Inc.+to+be+Renamed+Coeptis+Therapeutics%2C+Inc./18662173.html</guid>
   <pubDate>Fri, 09 Jul 2021 16:05:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Vinings Holdings, Inc. to be Renamed Coeptis Therapeutics, Inc.</title>
   <link>http://www.streetinsider.com/PRNewswire/Vinings+Holdings%2C+Inc.+to+be+Renamed+Coeptis+Therapeutics%2C+Inc./18662173.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Vinings+Holdings%2C+Inc.+to+be+Renamed+Coeptis+Therapeutics%2C+Inc./18662173.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Vinings+Holdings%2C+Inc.+to+be+Renamed+Coeptis+Therapeutics%2C+Inc./18662173.html</guid>
   <pubDate>Fri, 09 Jul 2021 16:05:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Vinings Holdings, Inc. to be Renamed Coeptis Therapeutics, Inc.</title>
   <link>http://www.streetinsider.com/PRNewswire/Vinings+Holdings%2C+Inc.+to+be+Renamed+Coeptis+Therapeutics%2C+Inc./18662173.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Vinings+Holdings%2C+Inc.+to+be+Renamed+Coeptis+Therapeutics%2C+Inc./18662173.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Vinings+Holdings%2C+Inc.+to+be+Renamed+Coeptis+Therapeutics%2C+Inc./18662173.html</guid>
   <pubDate>Fri, 09 Jul 2021 16:05:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Form  10-Q/A     VININGS HOLDINGS, INC.    For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-QA+++++VININGS+HOLDINGS%2C+INC.++++For%3A+Mar+31/18440949.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++10-QA+++++VININGS+HOLDINGS%2C+INC.++++For%3A+Mar+31/18440949.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-QA+++++VININGS+HOLDINGS%2C+INC.++++For%3A+Mar+31/18440949.html</guid>
   <pubDate>Tue, 18 May 2021 16:26:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Coeptis Pharmaceuticals Enters into Exclusive Option Agreements with VyGen-Bio to Co-develop Technologies Designed to Improve the Treatment of CD38-Related Cancers</title>
   <link>http://www.streetinsider.com/Press+Releases/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html</guid>
   <pubDate>Tue, 18 May 2021 08:33:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012008</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Coeptis Pharmaceuticals Enters into Exclusive Option Agreements with VyGen-Bio to Co-develop Technologies Designed to Improve the Treatment of CD38-Related Cancers</title>
   <link>http://www.streetinsider.com/Press+Releases/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html</guid>
   <pubDate>Tue, 18 May 2021 08:33:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012008</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Coeptis Pharmaceuticals Enters into Exclusive Option Agreements with VyGen-Bio to Co-develop Technologies Designed to Improve the Treatment of CD38-Related Cancers</title>
   <link>http://www.streetinsider.com/Press+Releases/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html</guid>
   <pubDate>Tue, 18 May 2021 08:33:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012008</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Coeptis Pharmaceuticals Enters into Exclusive Option Agreements with VyGen-Bio to Co-develop Technologies Designed to Improve the Treatment of CD38-Related Cancers</title>
   <link>http://www.streetinsider.com/PRNewswire/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html</guid>
   <pubDate>Tue, 18 May 2021 08:33:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012008</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Coeptis Pharmaceuticals Enters into Exclusive Option Agreements with VyGen-Bio to Co-develop Technologies Designed to Improve the Treatment of CD38-Related Cancers</title>
   <link>http://www.streetinsider.com/PRNewswire/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html</guid>
   <pubDate>Tue, 18 May 2021 08:33:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012008</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Coeptis Pharmaceuticals Enters into Exclusive Option Agreements with VyGen-Bio to Co-develop Technologies Designed to Improve the Treatment of CD38-Related Cancers</title>
   <link>http://www.streetinsider.com/PRNewswire/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Coeptis+Pharmaceuticals+Enters+into+Exclusive+Option+Agreements+with+VyGen-Bio+to+Co-develop+Technologies+Designed+to+Improve+the+Treatment+of+CD38-Related+Cancers/18437562.html</guid>
   <pubDate>Tue, 18 May 2021 08:33:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012008</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Form  10-Q       VININGS HOLDINGS, INC.    For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++VININGS+HOLDINGS%2C+INC.++++For%3A+Mar+31/18433645.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++VININGS+HOLDINGS%2C+INC.++++For%3A+Mar+31/18433645.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++VININGS+HOLDINGS%2C+INC.++++For%3A+Mar+31/18433645.html</guid>
   <pubDate>Mon, 17 May 2021 16:42:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Form  10-KT      VININGS HOLDINGS, INC.    For: Dec 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-KT++++++VININGS+HOLDINGS%2C+INC.++++For%3A+Dec+31/18402973.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++10-KT++++++VININGS+HOLDINGS%2C+INC.++++For%3A+Dec+31/18402973.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-KT++++++VININGS+HOLDINGS%2C+INC.++++For%3A+Dec+31/18402973.html</guid>
   <pubDate>Tue, 11 May 2021 16:49:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Form  8-K        VININGS HOLDINGS, INC.    For: May 11</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VININGS+HOLDINGS%2C+INC.++++For%3A+May+11/18401306.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VININGS+HOLDINGS%2C+INC.++++For%3A+May+11/18401306.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VININGS+HOLDINGS%2C+INC.++++For%3A+May+11/18401306.html</guid>
   <pubDate>Tue, 11 May 2021 14:21:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Form  8-K/A      VININGS HOLDINGS, INC.    For: Feb 12</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++VININGS+HOLDINGS%2C+INC.++++For%3A+Feb+12/18390609.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++VININGS+HOLDINGS%2C+INC.++++For%3A+Feb+12/18390609.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++VININGS+HOLDINGS%2C+INC.++++For%3A+Feb+12/18390609.html</guid>
   <pubDate>Mon, 10 May 2021 07:48:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Form  8-K        VININGS HOLDINGS, INC.    For: Apr 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VININGS+HOLDINGS%2C+INC.++++For%3A+Apr+30/18342301.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VININGS+HOLDINGS%2C+INC.++++For%3A+Apr+30/18342301.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VININGS+HOLDINGS%2C+INC.++++For%3A+Apr+30/18342301.html</guid>
   <pubDate>Fri, 30 Apr 2021 12:20:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Form  D          VININGS HOLDINGS, INC.               </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++D++++++++++VININGS+HOLDINGS%2C+INC.+++++++++++++++/18170643.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++D++++++++++VININGS+HOLDINGS%2C+INC.+++++++++++++++/18170643.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++D++++++++++VININGS+HOLDINGS%2C+INC.+++++++++++++++/18170643.html</guid>
   <pubDate>Wed, 24 Mar 2021 11:21:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
  <item>
   <title>Form  D          VININGS HOLDINGS, INC.               </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++D++++++++++VININGS+HOLDINGS%2C+INC.+++++++++++++++/18034929.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++D++++++++++VININGS+HOLDINGS%2C+INC.+++++++++++++++/18034929.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++D++++++++++VININGS+HOLDINGS%2C+INC.+++++++++++++++/18034929.html</guid>
   <pubDate>Thu, 25 Feb 2021 12:04:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NDYN</category>
   	  </item>
 </channel>
</rss>
